We are live on ! Find out more
PALI icon

Palisade Bio
PALI

96 hedge funds and large institutions have $262M invested in Palisade Bio in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

20% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 25

12% more funds holding

Funds holding: 86 → 96 (+10)

1.07% less ownership

Funds ownership: 91.19% → 90.12% (-1.1%)

18% less capital invested

Capital invested by funds: $319M → $262M (-$57.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
96
Holders Change
+10
Holders Change %
+11.63%
% of All Funds
1.18%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
31
Increased
30
Reduced
25
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BGI
B Group Inc
Texas
+$12.6M
2
Goldman Sachs
Goldman Sachs
New York
+$8.76M
3
Ameriprise
Ameriprise
Minnesota
+$8.36M
4
GPP
Great Point Partners
Connecticut
+$6.19M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$5.7M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$18.3M
2
SC
Stempoint Capital
New York
-$9.85M
3
CC
Commodore Capital
New York
-$7.75M
4
PA
Perceptive Advisors
New York
-$5.68M
5
VC
Vivo Capital
California
-$5.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$345K +$231K +126,977 +181%
Squarepoint
52
Squarepoint
New York
$345K -$228K -125,151 -39%
BNP Paribas Financial Markets
53
BNP Paribas Financial Markets
France
$331K +$344K +189,261 New
BFM
54
Boothbay Fund Management
New York
$297K +$67.3K +37,000 +28%
BC
55
BIT Capital
Germany
$271K -$273K -150,000 -49%
Qube Research & Technologies (QRT)
56
Qube Research & Technologies (QRT)
United Kingdom
$261K +$271K +148,970 New
PCM
57
Prelude Capital Management
New York
$233K +$242K +133,131 New
PFCS
58
Pale Fire Capital SE
Czech Republic
$195K +$74K +40,700 +58%
LPL Financial
59
LPL Financial
California
$193K +$173K +95,000 +627%
GCM
60
Graham Capital Management
Connecticut
$185K +$192K +105,832 New
SAM
61
Sectoral Asset Management
Quebec, Canada
$172K +$160K +88,000 New
Hudson Bay Capital Management
62
Hudson Bay Capital Management
Connecticut
$156K -$1.03M -567,074 -86%
Citigroup
63
Citigroup
New York
$153K +$64.4K +35,423 +68%
OAC
64
OMERS Administration Corp
Ontario, Canada
$146K -$44.9K -24,700 -23%
EC
65
EntryPoint Capital
New York
$139K +$145K +79,495 New
Charles Schwab
66
Charles Schwab
California
$133K +$138K +76,000 New
TRCT
67
Tower Research Capital (TRC)
New York
$94.2K +$96K +52,817 +5,153%
VGA
68
Vanguard Global Advisers
Pennsylvania
$91.5K +$95.1K +52,292 New
DC
69
Diametric Capital
Massachusetts
$90.8K +$94.3K +51,874 New
Vontobel Holding
70
Vontobel Holding
Switzerland
$78.8K +$45.5K +25,000 +125%
GCP
71
GSA Capital Partners
United Kingdom
$77K +$79.5K +43,730 New
JFG
72
Jefferies Financial Group
New York
$61K -$21.6K -11,886 -25%
SSA
73
Schonfeld Strategic Advisors
New York
$58K +$39.9K +21,915 +195%
CFM
74
Catalyst Funds Management
Australia
$55K +$57.1K +31,400 New
Two Sigma Investments
75
Two Sigma Investments
New York
$48.4K – – –
1 2
3
4 5

PALI Hedge Fund Activity: Q1 2026 in Review

96 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q1 2026, worth a combined $262M — down 18% from $319M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PALI positions and 20 closed out — a net gain of 11 holders — while 30 added to existing stakes and 25 trimmed.

The largest buyer was B Group Inc, adding an estimated $12.6M. The largest seller was Point72 Asset Management, cutting an estimated $18.3M.

  • 96 institutional investors held Palisade Bio (PALI) as of Q1 2026, up from 86 in Q4 2025.
  • Funds reported $262M of Palisade Bio stock for Q1 2026, down 18% quarter-over-quarter.
  • 31 funds opened new Palisade Bio positions in Q1 2026 and 20 closed out, a net change of +11 holders.
  • The largest Palisade Bio buyer in Q1 2026 was B Group Inc, an estimated $12.6M added.
  • The largest Palisade Bio seller in Q1 2026 was Point72 Asset Management, an estimated $18.3M sold.

Based on aggregated 13F filings for Q1 2026.